Cargando…
Simvastatin and Losartan Differentially and Synergistically Inhibit Atherosclerosis in Apolipoprotein E(-/-) Mice
BACKGROUND AND OBJECTIVES: Since statins and angiotensin receptor blockers are a frequently prescribed combination in patients with atherosclerotic cardiovascular diseases, we tested the interactive effects of simvastatin and losartan on atherosclerosis in apolipoprotein E (apoE)(-/-) mice. MATERIAL...
Autores principales: | Lee, Bok-Soo, Choi, Jin Yong, Kim, Joo Yun, Han, Seul Hee, Park, Jeong Euy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438264/ https://www.ncbi.nlm.nih.gov/pubmed/22977450 http://dx.doi.org/10.4070/kcj.2012.42.8.543 |
Ejemplares similares
-
Hypoxanthine induces cholesterol accumulation and incites atherosclerosis in apolipoprotein E‐deficient mice and cells
por: Ryu, Hye‐Myung, et al.
Publicado: (2016) -
The Role of Iron in Atherosclerosis in Apolipoprotein E Deficient Mice
por: Ma, Juan, et al.
Publicado: (2022) -
The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice
por: Ku, Eu Jeong, et al.
Publicado: (2022) -
Extract of Curcuma zedoaria R. prevents atherosclerosis in apolipoprotein E-deficient mice
por: Kim, Ki Mo, et al.
Publicado: (2021) -
TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
por: Watt, Victoria, et al.
Publicado: (2011)